[{"PropertyPlantAndEquipmentNet_0_Q2_USD":4235000.0,"MarketableSecuritiesCurrent_0_Q2_USD":7160000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":11978000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":6741000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":36977040.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":37036683.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-889000.0,"Depreciation_2_Q2_USD":734000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":113000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1384616.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":0.0,"AssetsCurrent_0_Q2_USD":309188000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":449000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OtherReceivables_0_Q2_USD":3597000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":9978000.0,"Assets_0_Q2_USD":320651000.0,"ShareBasedCompensation_2_Q2_USD":5240000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":4631000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":25.08,"DeferredIncomeTaxAssetsNet_0_Q2_USD":2038000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":23.33,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":20.95,"OperatingIncomeLoss_2_Q2_USD":-48247000.0,"OperatingIncomeLoss_1_Q2_USD":-26667000.0,"OtherNonoperatingExpense_2_Q2_USD":14000.0,"OtherNonoperatingExpense_1_Q2_USD":7000.0,"CommonStockSharesIssued_0_Q2_shares":37109506.0,"Liabilities_0_Q2_USD":75562000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":10719000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":3540000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":20205000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":14.06,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":-4622000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-1000.0,"PrepaidExpenseCurrent_0_Q2_USD":2129000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.7559,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q2_pure":0.7644,"IncomeTaxExpenseBenefit_2_Q2_USD":-558000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-421000.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":-445000.0,"CommonStockValue_0_Q2_USD":385454000.0,"InvestmentIncomeNet_2_Q2_USD":102000.0,"InvestmentIncomeNet_1_Q2_USD":38000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":-125000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":-94000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":632000.0,"RestrictedCash_0_Q2_USD":218000.0,"CommonStockNoParValue_0_Q2_USD":null,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":3750000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":10337000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-26309000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-47726000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1155000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0072,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q2_pure":0.0092,"OtherAssetsNoncurrent_0_Q2_USD":341000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":293635000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ResearchAndDevelopmentExpense_2_Q2_USD":36714000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q2_pure":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":35.79,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":3438000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-48284000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-26730000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3183000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-32285000.0,"LiabilitiesCurrent_0_Q2_USD":23223000.0,"AccountsPayableCurrent_0_Q2_USD":3303000.0,"NonoperatingIncomeExpense_2_Q2_USD":-37000.0,"NonoperatingIncomeExpense_1_Q2_USD":-63000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":293853000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":632000.0,"RestrictedCashNoncurrent_0_Q2_USD":218000.0,"IncreaseDecreaseInOtherReceivables_2_Q2_USD":-556000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.046,"PreferredStockNoParValue_0_Q2_USD":null,"IncreaseDecreaseInDeferredIncomeTaxes_2_Q2_USD":626000.0,"ShortTermLeaseCost_2_Q2_USD":5000.0,"ShortTermLeaseCost_1_Q2_USD":2000.0,"CashEquivalentsAtCarryingValue_0_Q2_USD":293635000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":293853000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":203283.0,"ProvisionForLoanAndLeaseLosses_2_Q2_USD":748000.0,"OperatingLeasePayments_2_Q2_USD":605000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":38000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":62000.0,"CommonStockSharesOutstanding_0_Q2_shares":37109506.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-32543000.0,"LeaseCost_1_Q2_USD":480000.0,"PreferredStockValue_0_Q2_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":3.11,"OperatingLeaseCost_2_Q2_USD":843000.0,"OperatingLeaseCost_1_Q2_USD":424000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":320651000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2778000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":39800000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":55451.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":758000.0,"OperatingExpenses_2_Q2_USD":48692000.0,"OperatingExpenses_1_Q2_USD":26946000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":705000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.71,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.29,"ProfitLoss_2_Q2_USD":-47726000.0,"OtherLiabilitiesCurrent_0_Q2_USD":934000.0,"StockholdersEquity_0_Q2_USD":245089000.0,"IncreaseDecreaseInIncomeTaxes_2_Q2_USD":44000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":48799000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1201000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":9978000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-54000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":5258005.0,"VariableLeaseCost_2_Q2_USD":110000.0,"VariableLeaseCost_1_Q2_USD":54000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-151084000.0,"LeaseCost_2_Q2_USD":958000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":8763000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":925000.0,"Ticker":"RPTX","CIK":"1808158","name":"REPARE THERAPEUTICS INC.","OfficialName":"Repare Therapeutics Inc. Common Shares","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"491202113.0","Country":"Canada","Sector":"nan","Industry":"nan","Market":"NASDAQ","SP500":"nan","filed":"20210812"}]